Hepatology News

Inventiva Bolsters Executive Team Ahead of Lanifibranor Phase 3 Data

FDA · 8 min

CRISPR Therapeutics' CASGEVY Reaches 60,000+ Eligible Patients Across 10 Countries Following Global Approvals

Hematology/Blood Disorders · 3 min

IPEC Excipient World Biologics Summit 2026: Recap

general · 3 min

Novo Nordisk's Denecimig Shows Significant Bleeding Reduction in Hemophilia A Phase 3 Trial Published in NEJM

Hemophilia A · 3 min

Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Hemophilia A Stem Cell Therapy

FDA · 2 min